3428
R.G. Soengas, A.M.S. Silva / Tetrahedron 69 (2013) 3425e3431
w/v cerium(IV) sulfate and 5% ammonium molybdate in 2 M sulfuric
acid or 0.5% ninhydrin in methanol. Purification via flash column
chromatography was performed on Sorbsil C60 40/60 silica. Nuclear
magnetic resonance spectroscopy (NMR) spectra were recorded on
a Bruker Avance 300 spectrometer in the deuterated solvent stated.
Optical rotations were measured on a PerkineElmer 241 polarimeter
0.11, 0.10 (2s, 6H, 2ꢁ CH3). 13C NMR (75 MHz, CDCl3):
¼112.3, 101.7
d
(2ꢁ eCe), 98.2, 85.9, 81.2, 78.2, 71.0 (5ꢁ eCHe), 67.9, 66.9 (2ꢁ
eCH2e), 52.2 (eCe), 28.3, 26.0 (2ꢁ CH3), 25.5 [eC(CH3)3], 24.6, 19.0
(2ꢁ CH3), 17.9 [eC(CH3)3], ꢀ4.8, ꢀ5.4 (2ꢁ CH3). MS (ESIþ) m/z (%)
434 ([MþH]þ, 100); HRMS (ESIþ) calcd for [C20H40NO7Si]þ, [MþH]þ
434.2561, found 434.2569.
with a path length of 10 cm. Concentrations are quoted in g 100 mLꢀ1
.
Low resolution mass spectra were recorded using electrospray ion-
ization (ESI), on Micromass BioQ II-ZS, Micromass 500 OAT, Micro-
mass TofSpec 2E, Micromass GCT, or Micromass Platform 1 mass
spectrometers. High resolution mass spectra (HRMS) were measured
on a Waters 2790-Micromass LCT by ESI.
4.2.4. 6-Amino-1-O-benzyl-6-deoxy-2,3-di-O-isopropylidene-a-D-
22
mannofuranose (4d). [
CDCl3):
a
]
ꢀ8.0 (c 0.8, CDCl3). 1H NMR (300 MHz,
D
d
¼7.63e7.26 (m, 5H, AreH), 5.08 (s, 1H, 1H), 4.87 (dd,
J3,2¼5.9 Hz, J3,4¼3.5 Hz, 1H, 3H), 4.70e4.47 (m, 3H, eCH2Ph, 2H),
4.23e4.20 (m, 1H, 5H), 4.02 (dd, J4,5¼7.2 and J4,3¼3.5 Hz, 1H, 4H),
3.77e3.59 (m, 2H, 6H, 60H), 2.12 (br s, 3H, eNH2, eOH), 1.45, 1.30
4.2. General procedure for the synthesis of aminoalcohols
4aei
(2s, 6H, 2ꢁ CH3). 13C NMR (75 MHz, CDCl3):
¼137.5 (eCe), 128.4,
d
128.0, 127.9, 127.8 (5ꢁ eCHe), 112.5 (eCe), 105.6 (eCHe), 84.7,
81.4, 79.9 (3ꢁ eCHe), 69.2 (eCH2e), 64.6 (eCHe), 54.7 (eCH2e),
26.3, 24.5 (2ꢁ CH3). MS (ESIþ) m/z (%) 310 ([MþH]þ, 100); HRMS
(ESIþ) calcd for [C16H24NO5]þ, [MþH]þ 310.1654, found 310.1672.
Bromonitroalkane (1.2 mmol) was added to a suspension of
activated zinc powder (654 mg, 10.0 mol) and indium powder
(14.3 mg, 0.13 mmol) in THF (5 mL) and the mixture was sonicated
for 20 min. The corresponding aldehyde (1.0 mmol) was added and
sonication was continued for a further 4 h. Then, isopropyl alcohol
(11 mL), hydrochloric acid (8 mL, 1 M) and zinc (327 mg, 5.0 mmol)
were added and the reaction mixture was stirred at room tem-
perature for 14 h. The mixture was then neutralized with saturated
aqueous sodium hydrogen carbonate, filtered through a pad of
Celite and extracted with ethyl acetate (3ꢁ50 mL). The combined
organic layers were dried over magnesium sulfate, filtered, and the
solvent was evaporated in vacuo. The residue was filtered through
a pad of silica gel eluting with CH2Cl2 to CH2Cl2/MeOH 9:1.
4.2.5. 5-[2-(Amino)propan-2-yl]-3-O-benzyl-1,2-O-isopropylidene-
a
-
D
-xylofuranose (4e). [
a
]
22 ꢀ3.8 (c 0.3, CDCl3). 1H NMR (300 MHz,
D
CDCl3):
d
¼7.38e7.28 (m, 5H, AreH), 5.99 (d, J1,2¼3.9 Hz, 1H, 1H),
4.72 (d, J¼11.8 Hz, 1H, eCHPh), 4.59 (d, J2,1¼3.9 Hz, 1H, 2H), 4.54 (d,
J¼11.8 Hz, 1H, eCHPh), 4.27 (d, J4,5¼3.8 Hz, 1H, 4H), 4.10 (d,
J5,4¼3.8 Hz, 1H, 5H), 4.02 (s, 1H, 3H), 1.51, 1.45, 1.31 (3s, 12H, 4ꢁ
CH3). 13C NMR (75 MHz, CDCl3):
d¼136.1 (eCe), 128.7, 128.3, 128.0
(5ꢁ eCHe), 112.2 (eCe), 104.9 (eCHe), 84.4, 81.6, 76.3, 72.6 (4ꢁ
eCHe), 72.1 (eCH2e), 57.9 (eCe), 26.9, 26.3, 23.6, 21.6 (4ꢁ CH3).
MS (ESIþ) m/z (%) 338 ([MþH]þ, 100); HRMS (ESIþ) calcd for
[C18H28NO5]þ, [MþH]þ 338.1957, found 338.1962.
4.2.1. 6-Amino-1-O-tert-butyldiphenylsilyl-6-deoxy-2,3-di-O-iso-
22
propylidene-
NMR (300 MHz, CDCl3):
a
-
D
-mannofuranose (4a). [
a]
þ0.6 (c 3.9, CDCl3). 1H
4.2.6. 5-(5-Amino-2,2-dimethyl-1,3-dioxan-5-yl)-3-O-benzyl-1,2-O-
D
d
¼7.65e7.61 (m, 4H, AreH), 7.45e7.39 (m,
isopropylidene-
dioxan-5-yl)-3-O-benzyl-1,2-O-isopropylidene-
(4f). 1H NMR (300 MHz, CDCl3):
7.36e7.33 (m, 10H, AreH), 5.99
a
-
D
-xylofuranose and 5-(5-amino-2,2-dimethyl-1,3-
6H, AreH), 5.35 (s, 1H, 1H), 4.94 (dd, J3,2¼5.8 and J3,4¼3.7 Hz, 1H,
3H), 4.70 (d, J2,3¼5.8 Hz, 1H, 2H), 4.04 (dd, J4,5¼8.5 Hz, J4,3¼3.7 Hz,
a-L
-arabinofuranose
d
0
1H, 4H), 3.96e3.89 (m, 1H, 5H), 2.98 (dd, J6,5¼3.3 and J6,6 ¼13.0 Hz,
(d, J1,2¼3.9 Hz, 1H, 1H), 5.90 (d, J1,2¼3.8 Hz, 1H, 1H), 4.76e4.51 (m,
3H), 4.16e3.90 (m, 4H), 3.72e3.46 (m, 4H), 2.41 (br s, 3H, eNH2,
eOH),1.46,1.43,1.42,1.40,1.32,1.30 (6s, 24H, 8ꢁ CH3). Major isomer
1H, 6H), 2.75 (dd, J6 ,5¼7.8 and J6 ,6¼13.0 Hz, 1H, 60H), 2.07 (br s, 3H,
0
0
eNH2, eOH), 1.40, 1.31 (2s, 6H, 2ꢁ CH3), 1.06 [s, 9H, C(CH3)3]. 13C
NMR (75 MHz, CDCl3):
d
¼135.6, 135.5 (4ꢁ eCHe), 132.9, 132.6 (2ꢁ
anti (
D
-xylo): 13C NMR (75 MHz, CDCl3):
d
¼137.3 (eCe), 128.7,
eCe), 130.0, 129.9, 127.8, 127.7 (6ꢁ eCHe), 112.6 (eCe), 101.6
(eCHe), 86.6, 80.8, 79.9, 77.2 (4ꢁ eCHe), 51.4 (eCH2e), 26.7
[eC(CH3)3], 25.9, 24.7 (2ꢁ CH3), 19.2 [eC(CH3)3]. MS (ESIþ) m/z (%)
458 ([MþH]þ, 100); HRMS (ESIþ) calcd for [C25H36NO5Si]þ, [MþH]þ
458.2357, found 458.2349.
128.0, 127.8 (5ꢁ eCHe), 111.6 (eCe), 105.2 (eCHe), 98.1 (eCe),
82.7, 81.4, 78.8 (3ꢁ eCHe), 72.4 (eCH2e), 69.4 (eCHe), 67.6, 66.6
(2ꢁ eCH2e), 52.2 (eCe), 28.1, 26.8, 26.2, 18.9 (4ꢁ CH3). Minor
isomer syn (
L
-arabino): 13C NMR (75 MHz, CDCl3):
d
¼136.4 (eCe),
127.5, 128.3, 127.8 (5ꢁ eCHe), 111.6 (eCe), 105.2 (eCHe), 98.1
(eCe), 85.0, 81.7, 76.7 (3ꢁ eCHe), 72.0 (eCH2e), 70.7 (eCHe), 67.1,
66.4 (2ꢁ eCH2e), 51.9 (eCe), 26.9, 26.3, 25.4, 21.7 (4ꢁ CH3). MS
(ESIþ) m/z (%) 410 ([MþH]þ100); HRMS (ESIþ) calcd for
[C21H32NO7]þ [MþH]þ 410.2173, found 410.2198.
4.2.2. 5-[2-(Amino)propan-2-yl]-1-O-tert-butyldiphenylsilyl-2,3-di-
O-isopropylidene-
NMR (300 MHz, CDCl3):
a
-
D
-lyxofuranose (4b). [
a
]
22 þ4.0 (c 1.0, CDCl3). 1H
D
d¼7.68e7.60 (m, 4H, AreH), 7.41e7.35 (m,
6H, AreH), 5.35 (s, 1H, 1H), 4.98 (dd, J3,2¼5.8 and J3,4¼3.4 Hz, 1H,
3H), 4.65 (d, J2,3¼5.8 Hz, 1H, 2H), 4.58 (br s, 3H, eNH2, eOH), 4.19
(dd, J4,5¼8.9 and J4,3¼3.4 Hz, 1H, 4H), 3.75 (d, J5,4¼8.9 Hz, 1H, 5H),
1.42, 1.37 (2s, 6H, 2ꢁ CH3), 1.09e0.94 (m, 15H, 2ꢁ CH3, C(CH3)3),
4.2.7. 6-Amino-6-deoxy-1,2-O-isopropylidene-3-O-methyl-a-D-glu-
22
cofuranose (4g). [
CDCl3):
a]
þ2.8 (c 0.6, CDCl3). 1H NMR (300 MHz,
D
d
¼5.91 (d, J1,2¼3.7 Hz, 1H, 1H), 4.55 (d, J1,2¼3.7 Hz, 1H, 2H),
0.94, 0.91 (2s, 6H, 2ꢁ CH3). 13C NMR (75 MHz, CDCl3):
d
¼135.5,
4.32e4.28 (m, 1H), 4.14e4.10 (m, 1H), 3.89 (d, J¼3.0 Hz, 1H), 3.46 (s,
3H, OCH3), 3.44e3.38 (m, 1H, 60H), 3.22e3.15 (m, 1H, 6H), 2.81 (br s,
1H, eOH), 1.48, 1.22 (2s, 6H, 2ꢁ CH3). 13C NMR (75 MHz, CDCl3):
135.4 (4ꢁ eCHe), 133.1, 132.8 (2ꢁ eCe), 129.9, 129.8, 127.7, 127.6
(6ꢁ eCHe), 112.1 (eCe), 101.8 (eCHe), 85.8, 81.1, 80.0, 69.9 (4ꢁ
eCHe), 53.4 (eCe), 26.9 [eC(CH3)3], 25.9, 24.6, 19.4, 19.0 (4ꢁ CH3),
18.2 (eCe). MS (ESIþ) m/z (%) 486 ([MþH]þ, 100); HRMS (ESIþ)
calcd for [C27H40NO5Si]þ [MþH]þ 486.2676 found 486.2682.
d
¼111.8 (eCe), 105.1 (eCHe), 83.4, 81.5, 81.264.8 (4ꢁ eCHe), 58.1
(eCH3), 43.4 (eCH2e), 26.7, 26.2 (2ꢁ CH3). MS (ESIþ) m/z (%) 234
([MþH]þ, 100); HRMS (ESIþ) calcd for [C10H20NO5]þ, [MþH]þ
234.1336, found 234.1314.
4.2.3. 5-(5-Aminoethyl-2,2-dimethyl-1,3-dioxan-5-yl)-1-O-tert-bu-
22
tyldimethylsilyl-2,3-di-O-isopropylidene-
a
-
D
-lyxofuranose (4c). [
a
]
4.2.8. 7-Deoxy-7-amino-1,2:3,4-di-O-isopropylidene-D-glycero-b-D-
D
22
þ2.6 (c 0.32, CDCl3). 1H NMR (300 MHz, CDCl3):
d
¼5.31 (s, 1H, 1H),
galactoheptose (4h). [
CDCl3):
a
]
ꢀ6.2 (c 0.2, CDCl3). 1H NMR (300 MHz,
D
4.89 (dd, J3,2¼5.8 and J3,4¼3.7 Hz, 1H, 3H), 4.49 (d, J2,3¼5.8 Hz, 1H,
2H), 4.17 (dd, J4,5¼8.77 and J4,3¼3.7 Hz, 1H, 4H), 4.05e3.97 (m, 2H,
2ꢁ eOCHe), 3.69e3.60 (m, 3H, 2ꢁ eOCHe, 5H), 1.97 (br s, 3H,
eNH2, eOH), 1.48, 1.44, 1.33 (3s, 12H, 4ꢁ CH3), 0.88 [s, 9H, C(CH3)3],
d
¼5.52 (d, J1,2¼5.1 Hz, 1H, 1H), 4.63 (dd, J3,2¼2.4 and
J3,4¼8.0 Hz, 1H, 3H), 4.47 (dd, J4,5¼1.8 and J4,3¼8.0 Hz, 1H, 4H), 4.32
(dd, J2,1¼5.1 and J2,3¼2.4 Hz, 1H, 2H), 3.79e3.75 (m, 1H, 6H), 3.62
(dd, J5,4¼1.8 and J5,6¼8.7 Hz, 1H, 5H), 2.99 (dd, J7,6¼3.3 Hz,